Another Low Priced Spec.
I’ve been spotty recently with my calls. My attempts to call an end to the rally have been premature and off. However, I have been right on with three recent low priced recommendations, and now have another. The Chart says to Buy AGE, here under .90. After the big surge on an announcement of partnering with another company on a specific cell therapy for diabetes treatment, AGE has pulled back to major support and is a long term value at this level. BUY. Chartsmaster
Are you aware it is about to be delisted due to capitalization issues?
Thanks for bringing it to my attention. I read that they are submitting plan to address it. Even if not accepted they go to OTC. Would prefer the plan is accepted but doesn’t change my outlook on the stock. The chart has already reflected the news but thanks again.
I hope they come up with something on the aging process. I take 600 mg of true Niagen and Pterostilbene daily and believe it works.
Ah….yes I can tell you have stopped aging Noman
🙂
I am just careful to not look at pictures of myself cause that’s not me! All of my indicators say not to but I am buying back my position…